ASX:NSB +61 8 6268 2641 ir@neuroscientific.com Level 4, 216 St Georges Terrace, PERTH, WA, AUSTRALIA, 6000 ASX Announcement 4 September 2026 Resignation and Appointment of Auditor NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) (“NSB” or the “Company”) advises...
Resignation and Appointment of Auditor
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Miro Sciences
- Appendix 4G & Corporate Governance Statement
- 2026 Annual Report & Appendix 4E
- Pre-IND Meeting with US FDA Scheduled
Later from Miro Sciences
- Letter to Shareholders & Proxy Form
- Notice of Annual General Meeting & Proxy Form
- Leading CRO Appointed for Phase 2 Crohn's Trial
- US FDA Provides Positive Feedback on Planned Phase 2 Trial
- Results of Annual General Meeting
Follow Miro Sciences into a list and get an email when it puts out news.
Follow Miro Sciences